Title: Pneumococcal Pneumonia in Alcoholism and HIV Infection
Abstract: Alcoholism: Clinical and Experimental ResearchVolume 22, Issue s5 p. 201S-203S Full Access Pneumococcal Pneumonia in Alcoholism and HIV Infection Martha J. Gentry, Corresponding Author Martha J. Gentry Infectious Diseases Laboratory, Research Service, Veterans Affairs Medical Center, Omaha, Nebraska.Reprint requests: Martha I. Gentry, Ph.D., Section of Infectious Diseases, Veterans Affairs Medical Center and the Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska.Search for more papers by this author Martha J. Gentry, Corresponding Author Martha J. Gentry Infectious Diseases Laboratory, Research Service, Veterans Affairs Medical Center, Omaha, Nebraska.Reprint requests: Martha I. Gentry, Ph.D., Section of Infectious Diseases, Veterans Affairs Medical Center and the Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska.Search for more papers by this author First published: 30 May 2006 https://doi.org/10.1111/j.1530-0277.1998.tb04001.xCitations: 5 Presented at the Alcohol-Induced Immunopathology Symposium, New Orleans, LA, October 17–18, 1997. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Mufson MA: Streptococcus pneumoniae, in GL Mandell, RG Douglas, JE Bennett (eds): Principles and Practice of Infectious Diseases, ed 3. New York , Churchill Livingstone, 1990, pp 1539–1550. 2 Winterbauer RH, Bedon GA, Ball WCJr: Recurrent pneumonia: Predisposing illness and clinical patterns in 158 patients. Ann Intern Med 70: 689–700, 1969. 3 Adams HG, Jordan C: Infections in the alcoholic. Med Clin N Am 68: 179–200, 1984. 4 Preheim LC, Gentry MJ: Infection in the alcoholic, in D Schlossberg (ed): Current Therapy of Infectious Disease. St Louis , Mosby, 1996, pp 308–311. 5 Janoff EN, Breiman RF, Daley CL, Hopewell PC: Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 117: 314–324, 1992. 6 Janoff EN, Rubins JB: Invasive pneumococcal disease in the immunocompromised host. Microbial Drug Resist 3: 215–232, 1997. 7 Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W, Hulley SB: HIV infection and behaviors among heterosexuals in alcohol treatment programs. JAMA 271: 515–518, 1994. 8 Balla AK, Lischner HW, Pomerantz RJ, Bagasra O: Human studies on alcohol and susceptibility to HIV infection. Alcohol 11: 99–103, 1994. 9 Westerberg VS: Alcohol measuring scales may influence conclusions about the role of alcohol in human immunodeficiency virus (HIV) risk and progression to acquired immunodeficiency syndrome (AIDS). Am J Epidemiol 135: 719–725, 1992. 10 National Institute on Alcohol Abuse and Alcoholism: Biomedical Research on Alcohol and AIDS, PA-95-067 NIH Guide 24(20) June 2 1995. 11 Osier W: The Principals and Practice of Medicine. New York , D. Appleton and Co., 1909. 12 Mufson MA, Kruss DM, Wasil RE, Metzger WI: Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 134: 505–510, 1974. 13 Gransden WR, Eykyn SJ, Phillips I: Pneumococcal bacteremia: 325 episodes diagnosed at St. Thomas's Hospital. Br Med J 290: 505–508, 1985. 14 Janoff EN, O'Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, Douglas JMJr: Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 167: 49–56, 1993. 15 Finkelstein MS, Petkun WM, Freedman ML, Antopol SC: Pneumococcal bacteremia in adults: Age-dependent differences in presentation and outcome. J Am Geriatric Soc 31: 19–27, 1983. 16 Hibbs JR, Douglas JMJr, Judson FN, McGill WL, Rietmeijer CAM, Janoff EN: Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984–1994. Clin Infect Dis 25: 195–199, 1997. 17 Hook EW III, Horton CA, Schaberg DR: Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 249: 1055–1057, 1983. 18 Cooper B, Maderazo EG: Alcohol abuse and impaired immunity. Infect Med 5: 479–487, 1988. 19 MacGregor RR: Alcohol and immune defense. JAMA 256: 1474–1479, 1986. 20 Gordon DL, Johnson GM, Hostetter MK: Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. J Infect Dis 154: 619–626, 1986. 21 Winkelstein JA: The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis 3: 289–298, 1981. 22 Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF: The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 174: 986–993, 1996. 23 U.S. Public Health Service Advisory Committee on Immunization Practices: Pneumococcal polysaccharide vaccine. MMWR 33: 410–419, 1981. 24 USPHS/IDSA Prevention of Opportunistic Infections Working Group: 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations. Clin Infect Dis 25 (Suppl. 3): S313–S335, 1997. 25 Carson PJ, Schut RL, Simpson ML, O'Brien J, Janoff EN: Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis 172: 340–345, 1995. 26 Simberkoff MS, Schiffman GS, Spicehandler JR, Moldover NH, Rahal JJJr: Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascites fluid of cirrhotic patients. J Clin Microbiol 18: 154–159, 1983. 27 Pirovino M, Lydick E, Grob PJ, Arrenbrecht S, Altorfer J, Schmid M: Pneumococcal vaccination: The response of patients with alcoholic liver cirrhosis. Hepatology 4: 946–949, 1984. 28 McMahon BJ, Parkinson AJ, Bulkow L, Davidson M, Wainwright K, Wolfe P, Schiffman GS: Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska native chronic alcoholics compared with nonalcoholic native and non-native controls. Am J Med 95: 589–594, 1993. 29 Henriksen JL, Preheim LC, Gentry MJ: Vaccination with protein-conjugated and native type 3 capsular polysaccharide in an ethanol-fed rat model of pneumococcal pneumonia. Alcohol Clin Exp Res 21: 1630–1637, 1998. Citing Literature Volume22, Issues5August 1998Pages 201S-203S ReferencesRelatedInformation